NASA Logo, External Link
Facebook icon, External Link to NASA STI page on Facebook Twitter icon, External Link to NASA STI on Twitter YouTube icon, External Link to NASA STI Channel on YouTube RSS icon, External Link to New NASA STI RSS Feed AddThis share icon
 

Record Details

Record 4 of 31
Recovery from vestibular ototoxicity
External Online Source: doi:10.1097/00129492-200109000-00018
Author and Affiliation:
Black, F. O.(Legacy Clinical Research and Technology Center, Neurotology Research, Portland, Oregon 97208-3950, United States)
Gianna-Poulin, C.
Pesznecker, S. C.
Abstract: OBJECTIVE: Determine whether subjects with documented vestibular ototoxicity recover vestibular function and, if so, investigate the recovery dynamics. STUDY DESIGN: Prospective and retrospective reviews and repeated measures. SETTING: Clinical research and technology center. SUBJECTS: Twenty-eight subjects who received vestibulotoxic medications were followed for at least 12 months after initial treatment. CONTROLS: Our subject sample was compared with a published database of normal individuals. INTERVENTIONS: All 28 subjects received systemically administered medications known to be ototoxic. The subjects' treating physicians controlled medication, dosage, and administration schedules. MAIN OUTCOME MEASURES: Tests of horizontal canal vestibulo-ocular function were performed. Subjects' auditory and vestibular symptoms were recorded. RESULTS: Eleven subjects (39%) showed changes in horizontal canal vestibulo-ocular gain constant (GC) and/or time constant (TC) consistent with vestibular ototoxicity. When tested 1 year after ototoxic drug administration, eight of the nine subjects who experienced ototoxic decrease in GC showed a recovery of GC to normal limits. Only one of the eight subjects who experienced ototoxic decrease in TC showed recovery of TC to within normal limits. Ototoxicity onset and recovery were independent of baseline vestibular function, and ototoxicity onset did not correlate with cumulative dose of ototoxic medication. There was no relationship between subjective symptoms and ototoxicity onset. CONCLUSIONS: Recovery of GC after vestibular ototoxicity is more commonly observed than recovery of TC. Because ototoxic changes developed and continued in an unpredictable time and manner in relation to ototoxic drug administration, we propose that once ototoxic changes in vestibulo-ocular reflex are detected, ototoxic medications should be discontinued as soon as possible.
Publication Date: Sep 01, 2001
Document ID:
20040088754
(Acquired Sep 07, 2004)
Subject Category: LIFE SCIENCES (GENERAL)
Document Type: Journal Article
Publication Information: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology (ISSN 1531-7129); Volume 22; 5; 662-71
Publisher Information: United States
Contract/Grant/Task Num: RO1 DC00205; RO1 NS 19221
Description: In English
Distribution Limits: Unclassified; Publicly available; Unlimited
Rights: Copyright
NASA Terms: ANTIINFECTIVES AND ANTIBACTERIALS; CHLORINE COMPOUNDS; PLATINUM COMPOUNDS; STREPTOMYCIN; VESTIBULES; ADULTS; AGE FACTOR; FEMALES; MALES; REFLEXES; VESTIBULAR NYSTAGMUS; VESTIBULAR TESTS
Other Descriptors: ANTI-BACTERIAL AGENTS/ADVERSE EFFECTS; ANTINEOPLASTIC AGENTS/ADVERSE EFFECTS; CISPLATIN/ADVERSE EFFECTS; GENTAMICINS/ADVERSE EFFECTS; STREPTOMYCIN/ADVERSE EFFECTS; TOBRAMYCIN/ADVERSE EFFECTS; VANCOMYCIN/ADVERSE EFFECTS; VESTIBULE/DRUG EFFECTS; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; REFLEX, VESTIBULO-OCULAR/DRUG EFFECTS; RETROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, NON-P.H.S; SUPPORT, U.S. GOV'T, P.H.S; VESTIBULAR FUNCTION TESTS; NASA DISCIPLINE NEUROSCIENCE; NON-NASA CENTER
Availability Source: Other Sources
› Back to Top
NASA Logo, External Link
NASA Official: Gerald Steeman
Site Curator: STI Program
Last Modified: August 23, 2011
Contact Us